These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

128 related articles for article (PubMed ID: 38164954)

  • 21. Evaluation of the European tick-borne encephalitis vaccine against Omsk hemorrhagic fever virus.
    Chidumayo NN; Yoshii K; Kariwa H
    Microbiol Immunol; 2014 Feb; 58(2):112-8. PubMed ID: 24329534
    [TBL] [Abstract][Full Text] [Related]  

  • 22. [TICK-BORNE ENCEPHALITIS VIRUS: EPIDEMIOLOGICAL AND CLINICAL PICTURE, DIAGNOSIS AND PREVENTION].
    Vilibić-Čavlek T; Barbić L; Pandak N; Pem-Novosel I; Stevanović V; Kaić B; Mlinarić-Galinović G
    Acta Med Croatica; 2014 Dec; 68(4-5):393-404. PubMed ID: 26285473
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Development and testing of a new tick-borne encephalitis virus vaccine candidate for veterinary use.
    Salát J; Formanová P; Huňady M; Eyer L; Palus M; Ruzek D
    Vaccine; 2018 Nov; 36(48):7257-7261. PubMed ID: 30337175
    [TBL] [Abstract][Full Text] [Related]  

  • 24. A systematic literature review of the effectiveness of tick-borne encephalitis vaccines in Europe.
    Angulo FJ; Zhang P; Halsby K; Kelly P; Pilz A; Madhava H; Moïsi JC; Jodar L
    Vaccine; 2023 Nov; 41(47):6914-6921. PubMed ID: 37858450
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Ability of inactivated vaccines based on far-eastern tick-borne encephalitis virus strains to induce humoral immune response in originally seropositive and seronegative recipients.
    Maikova GB; Chernokhaeva LL; Rogova YV; Kozlovskaya LI; Kholodilov IS; Romanenko VV; Esyunina MS; Ankudinova AA; Kilyachina AS; Vorovitch MF; Karganova GG
    J Med Virol; 2019 Feb; 91(2):190-200. PubMed ID: 30204244
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Exploring of primate models of tick-borne flaviviruses infection for evaluation of vaccines and drugs efficacy.
    Pripuzova NS; Gmyl LV; Romanova LIu; Tereshkina NV; Rogova YV; Terekhina LL; Kozlovskaya LI; Vorovitch MF; Grishina KG; Timofeev AV; Karganova GG
    PLoS One; 2013; 8(4):e61094. PubMed ID: 23585873
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Adjuvant/carrier activity of inactivated tick-borne encephalitis virus.
    Leibl H; Tomasits R; Eibl MM; Mannhalter JW
    Vaccine; 1998 Feb; 16(4):340-5. PubMed ID: 9607053
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Development and characterization of chimera of yellow fever virus vaccine strain and Tick-Borne encephalitis virus.
    Kuznetsova N; Siniavin A; Butenko A; Larichev V; Kozlova A; Usachev E; Nikiforova M; Usacheva O; Shchetinin A; Pochtovyi A; Shidlovskaya E; Odintsova A; Belyaeva E; Voskoboinikov A; Bessonova A; Vasilchenko L; Karganova G; Zlobin V; Logunov D; Gushchin V; Gintsburg A
    PLoS One; 2023; 18(5):e0284823. PubMed ID: 37163522
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Tick-Borne Encephalitis: An Update for the Special Operations Forces Provider.
    Kaur H; Shishido AA
    J Spec Oper Med; 2023 Jun; 23(2):110-113. PubMed ID: 37126779
    [TBL] [Abstract][Full Text] [Related]  

  • 30. [Immunological indices of human vaccination against tick-borne encephalitis using inactivated preparations with a varying concentration of the viral antigen].
    El'bert LB; Pervikov IuV; Krutianskaia GL; Krasil'nikov IV; Grachev VP
    Zh Mikrobiol Epidemiol Immunobiol; 1981 Jun; (6):89-92. PubMed ID: 7293574
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Humoral immunity against tick-borne encephalitis virus following manifest disease and active immunization.
    Klockmann U; Bock HL; Kwasny H; Praus M; Cihlová V; Tomková E; Krivanec K
    Vaccine; 1991 Jan; 9(1):42-6. PubMed ID: 2008800
    [TBL] [Abstract][Full Text] [Related]  

  • 32. [Reactogenicity and antigenic activity of a chromatographic cultured purified and concentrated inactivated dried vaccine against tick-borne encephalitis].
    Popov OV; Sumarokov AA; Shkol'nik RIa; El'bert LB; Vorob'eva MS
    Zh Mikrobiol Epidemiol Immunobiol; 1985 Jun; (6):34-9. PubMed ID: 3898672
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Evaluation of the Langat/dengue 4 chimeric virus as a live attenuated tick-borne encephalitis vaccine for safety and immunogenicity in healthy adult volunteers.
    Wright PF; Ankrah S; Henderson SE; Durbin AP; Speicher J; Whitehead SS; Murphy BR; Pletnev AG
    Vaccine; 2008 Feb; 26(7):882-90. PubMed ID: 18207289
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Tick-borne Langat/mosquito-borne dengue flavivirus chimera, a candidate live attenuated vaccine for protection against disease caused by members of the tick-borne encephalitis virus complex: evaluation in rhesus monkeys and in mosquitoes.
    Pletnev AG; Bray M; Hanley KA; Speicher J; Elkins R
    J Virol; 2001 Sep; 75(17):8259-67. PubMed ID: 11483771
    [TBL] [Abstract][Full Text] [Related]  

  • 35. [Detection of RNA in vaccine " EnceVir" against tick-borne encephalitis virus].
    Morozova OV; Tkachev SE; Chudinov AP
    Vopr Virusol; 2006; 51(3):42-6. PubMed ID: 16826756
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Tick-borne encephalitis: A comprehensive review of the epidemiology, virology, and clinical picture.
    Chiffi G; Grandgirard D; Leib SL; Chrdle A; Růžek D
    Rev Med Virol; 2023 Sep; 33(5):e2470. PubMed ID: 37392370
    [TBL] [Abstract][Full Text] [Related]  

  • 37. A tick-borne encephalitis virus vaccine based on the European prototype strain induces broadly reactive cross-neutralizing antibodies in humans.
    Orlinger KK; Hofmeister Y; Fritz R; Holzer GW; Falkner FG; Unger B; Loew-Baselli A; Poellabauer EM; Ehrlich HJ; Barrett PN; Kreil TR
    J Infect Dis; 2011 Jun; 203(11):1556-64. PubMed ID: 21592984
    [TBL] [Abstract][Full Text] [Related]  

  • 38. [A cultured concentrated inactivated vaccine against tick-borne encephalitis studied during the immunization of children and adolescents].
    Pavlova LI; Gorbunov MA; Vorob'eva MS; Karavanov AS; Grachev VP; Ladyshenskaia IP; Rasshchepkina MN; Mel'nikova LN; Lebedeva TM; Mel'nikov NA; Gusmanova AG; Deviatkov MIu; Rozanova EV; Mukachev MA
    Zh Mikrobiol Epidemiol Immunobiol; 1999; (6):50-3. PubMed ID: 10876850
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Full genome sequences and molecular characterization of tick-borne encephalitis virus strains isolated from human patients.
    Formanová P; Černý J; Bolfíková BČ; Valdés JJ; Kozlova I; Dzhioev Y; Růžek D
    Ticks Tick Borne Dis; 2015 Feb; 6(1):38-46. PubMed ID: 25311899
    [TBL] [Abstract][Full Text] [Related]  

  • 40. [Changes in the reproduction of tick-borne encephalitis virus in cell cultures].
    Morozova OV; Grishechkin AE; Bakhvalova VN; Isaeva EI; Podcherniaeva RIa
    Vopr Virusol; 2012; 57(2):40-3. PubMed ID: 22834147
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 7.